Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors

Cited by papers we hold 11

• Neoantigens: promising targets for cancer therapy · 2023
  No notice
• ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells · 2021
  No notice
• A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress · 2020
  Corrected
• REDIportal: millions of novel A-to-I RNA editing events from thousands of RNAseq experiments · 2020
  No notice
• RNA editing in the forefront of epitranscriptomics and human health · 2019
  No notice
• ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity · 2019
  No notice
• RNA editing derived epitopes function as cancer antigens to elicit immune responses · 2018
  No notice
• Whole transcriptome profiling of Late-Onset Alzheimer’s Disease patients provides insights into the molecular changes involved in the disease · 2018
  No notice
• Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs · 2017
  No notice
• Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance · 2017
  No notice
• Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.